MU Logo Department of Internal Medicine at MUMu Health Care

Cardiovascular Medicine Faculty

Greg Flaker, M.D., F.A.C.P., F.A.C.C., F.A.H.A.

Brent Parker Professor of Medicine
  • Program Director, Cardiovascular Disease Fellowship Program
  • Director, Division of Cardiovascular Medicine Research
  • Director, Electrophysiology Laboratory, University of Missouri .

Dr. Flaker’s primary areas of interest are atherosclerosis, cardiology electrophysiology, defibrillators and pacemakers.

Board Certifications

  • Internal Medicine
  • Cardiovascular Disease
Photo of Dr. Flaker

Medical School

University of Missouri - Columbia Columbia, Missouri


Residency

University of Missouri - Columbia Columbia, Missouri


Fellowship
Cardiovascular Disease

Ohio State University Columbus, Ohio

Organizations:

  • American Heart Association
  • American College of Physicians, Fellow
  • American College of Cardiology, Fellow
  • North American Society of Pacing and Electrophysiology
  • American Heart Association Council on clinical Cardiology
  • Missouri Chapter of American College of Cardiology, Fellow

Honors and Awards:

  • University of Missouri Medical Alumni Organization
  • Distinguished Service Award 2003
  • University of Missouri Alumni Association Faculty-Alumni
  • Award 2003
  • Who’s Who Among America’s Teachers 2004
  • Who’s Who in Medical Sciences 2005 

Recent Publications

  1. Murcia AM, Hennekens CH, Lamas GA, Jimenez-Navarro M, Rouleau JL, Flaker GC, Goldman S, Skali H, Braunwald E, Pfeffer MA. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. Archives Int Med 2004; 164 (20): 2273-9.
  2. Wen DY, Flaker G, Sharp RL, Smith PA. Atrial flutter in a college football player: Return to play or not? The Physician and Sportsmedicine 2003;31(#10):21-35.
  3. Flaker G, Schutz J. Why is warfarin underutilized in atrial fibrillation? J of Interventional Cardiac Electrophysiology 2004;10:21-25.
  4. Wasson S, Govindarajan G, Reddy HK, Flaker G Role of nitric oxide and vasopressin in refractory right heart failure J of Cardiovascular Pharmacology and Therapeutics 2004; Mar 9 (1) 9-11.
  5. Greenspon AJ, Hart R, Dawson D, Hellcamp AS, Silver M, Flaker GC, Schron E, Goldman L, Lee KL, Lamas GA for the MOST investigators Predictors of stroke in patients paced for sick sinus syndrome JACC 2004;43:1617-22.
  6. Flaker G, Shukla H, et al. Heart failure hospitalization is more common in pacemaker patients with sinus node dysfunction and a prolonged paced QRS duration. Heart Rhythm 2005; 2 (3) 245-51.
  7. Shukla HH, Flaker GC, Hellkamp AS, James EA, Lee KL, Goldman L, Orav EJ, Lamas GA. Clinical and quality of life comparison of accelerometer, piezoelectric crystal and blended sensors in DDDR-paced patients with sinus node dysfunction in the Mode Selection Trial (MOST). Pace 2005; 28(8): 762-70.
  8. Flaker GC, Belew K, Beckman KJ, Vidaillet H, Kron J, Safford R, Mickel M, Barrell P, and the AFFIRM Investigators. Asymptomatic Atrial Fibrillation: Demographic Features and Prognostic Information From the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. Am Heart J 2005;149:1-7.
  9. Wasson S, Tejwani L, Flaker G. Single Coronary artery with the absence of left anterior descending artery. Journal of Invasive Cardiology. 2005 In Press.
  10. Flaker G. "Show-me" the money. Heart Rhythm 2005; Vol. 2, Issue 4: 34-5.
  11. Khaja A, Flaker G. Bachmann's bundle: does it play a role in atrial fibrillation? PACE 2005; 28 (8) 855-863.
  12. Gosavi A, Gardner D, Flaker G. Lipid management reduces cardiovascular complications in diabetics and pre-diabetics. Preventive Cardiology. (In Press)
  13. Dimarco JP. Flaker G. Waldo AL. Corley SD, Greene HL. Safford RE. Rosenfeld LE. Mitrani G. Nemeth M. for the AFFIRM investigators. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005; 149(4): 650-6.
  14. Steinberg BA, Braganza AJM, Eminowicz G, Dibattiste PM, Flaker GC, Murphy SA, Cannon CP Are statins being underdosed in clinical practice? Data from TACTICS-TMI 18. Critical Pathways in Cardiology 2005 in press
Webmaster | ©2006 Curators of the University of Missouri DMCA and other copyright information
All rights reserved. An equal opportunity/ADA institution.
Last Revised: 01/23/2008